These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

62 related articles for article (PubMed ID: 3523572)

  • 21. Relapse prevention in schizophrenia: evidence from longterm, randomized, double-blind clinical trials.
    Pecenak J
    Neuro Endocrinol Lett; 2007 Feb; 28 Suppl 1():49-70. PubMed ID: 17262007
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Use of ceruletide in cholecystography].
    Orzechowska R; Baron J
    Pol Tyg Lek; 1981 Oct; 36(40):1549-51. PubMed ID: 7038641
    [No Abstract]   [Full Text] [Related]  

  • 23. [Double-blind or open mind?].
    Huttunen JK
    Duodecim; 1986; 102(16):1129-33. PubMed ID: 3757849
    [No Abstract]   [Full Text] [Related]  

  • 24. Adjunctive estrogen treatment in women with chronic schizophrenia: a double-blind, randomized, and placebo-controlled trial.
    Akhondzadeh S; Nejatisafa AA; Amini H; Mohammadi MR; Larijani B; Kashani L; Raisi F; Kamalipour A
    Prog Neuropsychopharmacol Biol Psychiatry; 2003 Sep; 27(6):1007-12. PubMed ID: 14499318
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Statistical methods in the evaluation of the therapeutic efficacy--their problems and solutions].
    Tominaga S
    Gan To Kagaku Ryoho; 1982 Nov; 9(11):1873-81. PubMed ID: 6764094
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Regarding "N-acetyl cysteine as a glutathione precursor for schizophrenia--a double-blind, randomized, placebo-controlled trial".
    Hashimoto K
    Biol Psychiatry; 2008 Nov; 64(9):e1. PubMed ID: 18718574
    [No Abstract]   [Full Text] [Related]  

  • 27. Hemoperfusion for chronic schizophrenia: preliminary psychiatric results.
    Kinney MJ; Varga E; Varga V; Tarter R; Sugerman AA; Nilsen S; Gupta G
    J Clin Psychiatry; 1981 Apr; 42(4):175-7. PubMed ID: 7009594
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pimozide versus chlorpromazine in chronic schizophrenia: a 52 week double-blind study of maintenance therapy.
    Wilson LG; Roberts RW; Gerber CJ; Johnson MH
    J Clin Psychiatry; 1982 Feb; 43(2):62-5. PubMed ID: 7035441
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Beneficial antipsychotic effects of allopurinol as add-on therapy for schizophrenia: a double blind, randomized and placebo controlled trial.
    Akhondzadeh S; Safarcherati A; Amini H
    Prog Neuropsychopharmacol Biol Psychiatry; 2005 Feb; 29(2):253-9. PubMed ID: 15694232
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Hydergine for schizophrenia.
    Cohen MR; Pary R; Burns R
    J Clin Psychiatry; 1987 Jan; 48(1):39-40. PubMed ID: 3542983
    [No Abstract]   [Full Text] [Related]  

  • 31. A double-blind placebo controlled study of cinnarizine in the prophylaxis of seasickness.
    Hargreaves J
    Practitioner; 1980 May; 224(1343):547-50. PubMed ID: 6999486
    [No Abstract]   [Full Text] [Related]  

  • 32. [Evaluation of clinical trials].
    Gøtzsche PC
    Ugeskr Laeger; 1986 Sep; 148(38):2417-20. PubMed ID: 3765176
    [No Abstract]   [Full Text] [Related]  

  • 33. Suicide risk in placebo vs active treatment in placebo-controlled trials for schizophrenia.
    Storosum JG; van Zwieten BJ; Wohlfarth T; de Haan L; Khan A; van den Brink W
    Arch Gen Psychiatry; 2003 Apr; 60(4):365-8. PubMed ID: 12695313
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Changes in the eye movements of chronic schizophrenics as a result of treatment with a CCK-8-like drug (caerulein)].
    Sudo K; Koyama T; Ichikawa J; Yasuda M; Kazawa T
    Seishin Shinkeigaku Zasshi; 1983; 85(11):805-7. PubMed ID: 6677916
    [No Abstract]   [Full Text] [Related]  

  • 35. [The controlled clinical treatment trial: full of problems, but necessary].
    Wulff HR
    Ugeskr Laeger; 1987 Oct; 149(41):2814-5. PubMed ID: 3451531
    [No Abstract]   [Full Text] [Related]  

  • 36. Reduced cholecystokinin levels in cerebrospinal fluid of parkinsonian and schizophrenic patients. Effect of ceruletide in schizophrenia.
    Lotstra F; Verbanck PM; Gilles C; Mendlewicz J; Vanderhaeghen JJ
    Ann N Y Acad Sci; 1985; 448():507-17. PubMed ID: 3896098
    [No Abstract]   [Full Text] [Related]  

  • 37. Ceruletide reduces postoperative intestinal paralysis. A double-blind placebo-controlled trial.
    Madsen PV; Lykkegaard-Nielsen M; Nielsen OV
    Dis Colon Rectum; 1983 Mar; 26(3):159-60. PubMed ID: 6337791
    [No Abstract]   [Full Text] [Related]  

  • 38. Clinical study on the psychotropic effects of caerulein--an open clinical trial in chronic schizophrenic patients.
    Itoh H; Tanoue S; Yagi G; Tateyama M; Kamisada M; Fujii Y; Takamiya M; Nakajima S
    Keio J Med; 1982 Oct; 31(3):71-95. PubMed ID: 6764226
    [No Abstract]   [Full Text] [Related]  

  • 39. [Value of the use of ceruletide in patients undergoing cholecystectomy].
    Sirchi M; Peroni L
    Atti Accad Med Lomb; 1975; 30(1-3):25-8. PubMed ID: 1234849
    [No Abstract]   [Full Text] [Related]  

  • 40. Comment on a letter on the elimination of treatment predictability.
    Thompson DA
    Br J Clin Pharmacol; 1986 Apr; 21(4):463. PubMed ID: 3707816
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.